# EDGAR Filing Document

**Accession Number:** 0001577916
**File Stem:** 0001193125-23-005203
**Filing Date:** 2023-1
**Character Count:** 30626
**Document Hash:** 2cec6fb09ef84809c01582aedcb3413b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-005203.hdr.sgml**: 20230110

**ACCESSION NUMBER**: 0001193125-23-005203

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 25

**CONFORMED PERIOD OF REPORT**: 20230110

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230110

**DATE AS OF CHANGE**: 20230110

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Premier, Inc.
- **CENTRAL INDEX KEY:** 0001577916
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT SERVICES [8741]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36092
- **FILM NUMBER:** 23519749

**BUSINESS ADDRESS:**
- **STREET 1:** 13034 BALLANTYNE CORPORATE PLACE
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277
- **BUSINESS PHONE:** 704-357-0022

**MAIL ADDRESS:**
- **STREET 1:** 13034 BALLANTYNE CORPORATE PLACE
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277

?xml version="1.0" encoding="utf-8" ? Form 8-K

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### FORM 8-K

------

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of The Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): January 10, 2023

------

## Premier, Inc.

#### (Exact name of Registrant as specified in its charter)

------

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-36092** | **35-2477140** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

#### 13034 Ballantyne Corporate Place

#### Charlotte, NC 28277

#### (Address of principal executive offices, including zip code)
(704) 357-0022

#### (Registrant's telephone number, including area code)

#### Not Applicable

#### (Former name or former address, if changed since last report)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered or to be registered pursuant to Section 12(b) of the Act.

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Class A Common Stock, $0.01 Par Value | PINC | NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 7.01.** | **Regulation FD Disclosure.**  |

---

Premier, Inc. (the "Company") is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10, 2023 at 11:15 a.m. Pacific Time. The presentation and subsequent breakout question and answer session will be audio webcast live through the Company's investor relations website page at <u>investors.premierinc.com</u>, where presentation slides also will be made available. A webcast replay will be archived on the Company's website for approximately 90 days.

Pursuant to Regulation FD, the Company hereby furnishes the presentation materials attached as Exhibit 99.1 to this Current Report on Form 8-K, which information is incorporated into this Item 7.01 by this reference. A related press release announcing the Company's participation in the conference is also attached as Exhibit 99.2 to this Current Report on Form 8-K, which information is incorporated into this Item 7.01 by this reference.

The information in this Current Report on Form 8-K under this Item 7.01, as well as Exhibit 99.1 and Exhibit 99.2, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing. The furnishing of this report is not intended to constitute a determination by the registrant that the information is material or that the dissemination of the information is required by Regulation FD.

The information included in this Current Report on Form 8-K and any exhibits hereto will not be deemed an admission as to the materiality of any such information.

#### Use and Definition of Non-GAAP Financial Measures
The financial data contained in the presentation materials attached hereto as Exhibit 99.1 includes financial measures that are not calculated in accordance with generally accepted accounting principles ("Non-GAAP"), including EBITDA, Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Fully Distributed Net Income, Adjusted Fully Distributed Earnings per Share and Free Cash Flow, each as defined below.

The Company defines EBITDA as net income before loss from discontinued operations, net of tax, interest and investment income, net, income tax expense, depreciation and amortization and amortization of purchased intangible assets. The Company defines Adjusted EBITDA as EBITDA before merger and acquisition related expenses and non-recurring, non-cash or non-operating items and including equity in net income of unconsolidated affiliates. For all Non-GAAP financial measures, the Company considers non-recurring items to be income or expenses and other items that have not been earned or incurred within the prior two years and are not expected to recur within the next two years. Such items include certain strategic and financial restructuring expenses. Non-operating items include gains or losses on the disposal of assets and interest and investment income or expense.

The Company defines Segment Adjusted EBITDA as the segment's net revenue less cost of revenue and operating expenses directly attributable to the segment, excluding depreciation and amortization, amortization of purchased intangible assets, merger and acquisition related expenses and non-recurring or non-cash items, and including equity in net income of unconsolidated affiliates. Operating expenses directly attributable to the segment include expenses associated with sales and marketing, general and administrative, and product development activities specific to the operation of each segment. General and administrative corporate expenses that are not specific to a particular segment are not included in the calculation of Segment Adjusted EBITDA. Segment Adjusted EBITDA also excludes any income and expense that has been classified as discontinued operations.

The Company defines Adjusted Fully Distributed Net Income as net income attributable to the Company (i) excluding loss from discontinued operations, net, (ii) excluding income tax expense, (iii) excluding the impact of adjustment of redeemable limited partners' capital to redemption amount, (iv) excluding the effect of non-recurring and non-cash items, (v) assuming the exchange of all the Class B common units for shares of Class A common stock, which results in the elimination of non-controlling interest in Premier Healthcare Alliance, L.P., and (vi) reflecting an adjustment for income tax expense on Non-GAAP fully distributed net income before income taxes at the Company's estimated effective income tax rate. The Company defines Adjusted Fully Distributed Earnings per Share as Adjusted Fully Distributed Net Income divided by diluted weighted average shares.

------

The Company defines Free Cash Flow as net cash provided by operating activities from continuing operations less distributions and tax receivable agreement payments to limited partners and purchases of property and equipment. Free Cash Flow does not represent discretionary cash available for spending as it excludes certain contractual obligations such as debt repayments.

Adjusted EBITDA and Free Cash Flow are supplemental financial measures used by the Company and by external users of its financial statements and are considered to be indicators of the operational strength and performance of the Company's business. Adjusted EBITDA and Free Cash Flow measures allow the Company to assess its performance without regard to financing methods and capital structure and without the impact of other matters that the Company does not consider indicative of the operating performance of its business. More specifically, Segment Adjusted EBITDA is the primary earnings measure the Company uses to evaluate the performance of its business segments.

The Company uses Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Fully Distributed Net Income and Adjusted Fully Distributed Earnings per Share to facilitate a comparison of its operating performance on a consistent basis from period to period that, when viewed in combination with the Company's results prepared in accordance with GAAP, provides a more complete understanding of factors and trends affecting its business. The Company believes Adjusted EBITDA and Segment Adjusted EBITDA assist its board of directors, management and investors in comparing the Company's operating performance on a consistent basis from period to period because they remove the impact of earnings elements attributable to the Company's asset base (primarily depreciation and amortization), certain items outside the control of its management team, e.g., taxes, other non-cash items (such as impairment of intangible assets, purchase accounting adjustments and stock-based compensation), non-recurring items (such as strategic and financial restructuring expenses) and income and expense that has been classified as discontinued operations from the Company's operating results. The Company believes Adjusted Fully Distributed Net Income and Adjusted Fully Distributed Earnings per Share assist its board of directors, management and investors in comparing its net income and earnings per share on a consistent basis from period to period because these measures remove non-cash (such as impairment of intangible assets, purchase accounting adjustments and stock-based compensation) and non-recurring items (such as strategic and financial restructuring expenses), and eliminate the variability of non-controlling interest that results from member owner exchanges of Class B common units for shares of Class A common stock. The Company believes Free Cash Flow is an important measure because it represents the cash that the Company generates after payment of tax distributions to limited partners and capital investment to maintain existing products and services and ongoing business operations, as well as development of new and upgraded products and services to support future growth. Free Cash Flow allows the Company to enhance stockholder value through acquisitions, partnerships, joint ventures, investments in related businesses and debt reduction.

Despite the importance of these Non-GAAP financial measures in analyzing the Company's business, determining compliance with certain financial covenants in its Credit Facility, measuring and determining incentive compensation and evaluating its operating performance relative to competitors, EBITDA, Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Fully Distributed Net Income, Adjusted Fully Distributed Earnings per Share and Free Cash Flow are not measurements of financial performance under GAAP, may have limitations as analytical tools and should not be considered in isolation from, or as an alternative to, net income, net cash provided by operating activities, or any other measure of the Company's performance derived in accordance with GAAP.

Some of the limitations of the EBITDA, Adjusted EBITDA and Segment Adjusted EBITDA measures include that they do not reflect: the Company's capital expenditures or its future requirements for capital expenditures or contractual commitments; changes in, or cash requirements for, its working capital needs; the interest expense or the cash requirements to service interest or principal payments under its Credit Facility; income tax payments the Company is required to make; and any cash requirements for replacements of assets being depreciated or amortized.

In addition, EBITDA, Adjusted EBITDA, Segment Adjusted EBITDA and Free Cash Flow are not measures of liquidity under GAAP, or otherwise, and are not alternatives to cash flows from operating activities. Some of the limitations of the Adjusted Fully Distributed Net Income and Adjusted Fully Distributed Earnings per Share measures are that they do not reflect income tax expense or income tax payments the Company is required to make. In addition, Adjusted Fully Distributed Net Income and Adjusted Fully Distributed Earnings per Share are not measures of profitability under GAAP. Because the EBITDA, Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Fully Distributed Net Income, Adjusted Fully Distributed Earnings per Share and Free Cash Flow measures are susceptible to varying calculations, such Non-GAAP financial measures may differ from, and may therefore not be comparable to, similarly titled measures used by other companies.

------

Non-recurring and non-cash items excluded in the Company's calculation of Adjusted EBITDA, Segment Adjusted EBITDA and Adjusted Fully Distributed Net Income consist of stock-based compensation, acquisition and disposition related expenses, remeasurement of tax receivable agreement liabilities, enterprise resource planning (ERP) implementation expenses, loss on FFF put and call rights, income and expense that has been classified as discontinued operations and other expense.

The Company urges investors to review the reconciliation of these Non-GAAP financial measures included in the Appendix to Exhibit 99.1 of this Form 8-K and in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 ("Form 10-Q"), filed with the United States Securities and Exchange Commission (the "SEC"). To properly and prudently evaluate the Company's business, investors should review (i) the unaudited consolidated financial statements and related notes included in the Form 10-Q, (ii) the audited consolidated financial statements and related notes included in the Company's Annual Report on Form 10-K for the year ended June 30, 2022, filed with the SEC, and (iii) the future periodic and current reports the Company files with the SEC, and investors should not rely on any single financial measure to evaluate the Company's business. In addition, because the EBITDA, Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Fully Distributed Net Income, Adjusted Fully Distributed Earnings per Share and Free Cash Flow measures are susceptible to varying calculations, such Non-GAAP financial measures, as presented in the presentation materials, may differ from, and may therefore not be comparable to, similarly titled measures used by other companies.

#### Forward-Looking Statements
Statements made in the presentation materials attached hereto as Exhibit 99.1 that are not statements of historical or current facts, including, but not limited to, those related to ability to deliver stockholder value through future investments and return capital to stockholders, ability to anticipate and address emerging healthcare trends and Premier's role in the future of healthcare, revenue visibility, free cash flow generation, strategic growth opportunities and priorities, and cross-selling capabilities are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as "believes," "belief," "expects," "estimates," "intends," "anticipates" or "plans" to be uncertain and forward-looking. Forward-looking statements may include comments as to the Company's beliefs and expectations as to future financial performance, events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the Company's control. More information on potential factors that could affect the Company's financial results is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's periodic and current filings with the SEC and made available on the Company's website at <u>investors.premierinc.com</u>. Forward looking statements speak only as of the date they are made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events that occur after that date, or otherwise.

#### Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.

---

| | |
|:---|:---|
| 99.1 | [Premier, Inc. Presentation Materials, dated January 10, 2023](d637065dex991.htm) |
| 99.2 | [Press Release of Premier, Inc., dated January 3, 2023](d637065dex992.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Premier, Inc. | Premier, Inc. |
| Date: January 10, 2023 | By: | /s/ Michael J. Alkire |
|  | Name: | Michael J. Alkire |
|  | Title: | President and Chief Executive Officer |

---

## Exhibit 99.1

**Exhibit 99.1**![LOGO](g637065g03c01.jpg)

EXHIBIT99.1 41st Annual J.P. Morgan Healthcare Conference Michael J. Alkire, President and CEO Craig McKasson, Chief Administrative and Financial Officer January 10, 2023

------

![LOGO](g637065g04c01.jpg)

Forward-Looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our long-term strategies, our ability to achieve fiscal 2023 guidance and multi-year compound annual growth targets for total net revenue, adjusted EBITDA and adjusted EPS, our continued ability to address the evolving healthcare trends in supply chain, staffing, technology-enablement and artificial intelligence, the impact of a shift to enterprise-level analytics agreements and our ability to replace converted SaaS-based revenue from existing members, the impact of our investments in adjacent markets businesses, our future organic growth and acquisition strategies, the impact of our subsidiary reorganization on our expected effective income tax rate, the payment of dividends at current levels, or at all, and the timing and number of shares repurchased under our share repurchase program, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as "believes," "belief," "expects," "estimates," "intends," "remains committed to," "anticipates" or "plans" to be uncertain and forward-looking. Forward-looking statements may include comments as to Premier's beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside Premier's control. More information on potential factors that could affect Premier's financial results is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Premier's periodic and current filings with the SEC, including those discussed under the "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" section of Premier's Form 10-K for the year ended June 30, 2022, as filed with the SEC and also available on Premier's website at investors.premierinc.com. Forward-looking statements speak only as of the date they are made, and Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events that occur after that date, or otherwise. Non-GAAP financial measures – This presentation and accompanying webcast may include certain "adjusted" or "non-GAAP" financial measures as defined in Regulation G under the Securities Exchange Act of 1934. You should carefully read Premier's periodic and current filings with the SEC for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation. Confidential© 2023. All rights reserved. Premier Inc. 2

------

![LOGO](g637065g05c01.jpg)

Premier, Inc. A Purpose-Driven Healthcare Improvement Company Through collaboration with our member health systems, customers and other stakeholders and leveraging technology-based solutions and supply chain capabilities, we help improve the delivery of healthcare while effectively reducing costs. Confidential© 2023. All rights reserved. Premier Inc. 3

------

![LOGO](g637065g06c01.jpg)

------

![LOGO](g637065g07c01.jpg)

Delivering Innovative Solutions to Drive Growth Group Purchasing Organization Collective purchasing power designed to lower non-labor costs without sacrificing outcomes across acute, non-acute and non-healthcare segments Direct sourcing business that drives meaningful cost savings in key shortage areas and improves domestic production as well as supply chain efficiencies, resiliency and transparency Supply Chain Services Large-Scale Provider Network Performance Services Proprietary suite of AI-enabled clinical, margin improvement and value-based care technology solutions Direct-to-employer contracting platform connecting self-insured employers and providers Supply chain-focused digital invoicing and payments platform Confidential© 2023. All rights reserved. Premier Inc. 5

------

![LOGO](g637065g08c01.jpg)

Recent Awards and Recognition The CEO Forum's 2022 "Top 10 CEOs Transforming Healthcare" Modern Healthcare's Top 100 Most Influential People in Healthcare List – Michael Alkire, CEO Newsweek's Most Trusted Companies 2022 Healthiest Employers® 2022 Top 100 Healthiest Workplaces in America – Ranked 23rd 2022 Best in KLAS for Value-Based Care Consulting 2022 World's Most Ethical Companies® Honoree by Ethisphere® Institute – 15th Consecutive Year Top 25 Women Leaders in Biotechnology of 2022 – Denise Juliano, Group Vice President, PINC AI™ Applied Sciences 10 Most Influential D&I Leaders 2022 – Joe Machicote, Chief Diversity and Inclusion Officer 2022 BWB Awards winner for innovative use of technology-enabled healthcare solutions in Digital Medicine category – PINC AI Applied Sciences, AstraZeneca and Clinithink Confidential© 2023. All rights reserved. Premier Inc. 6

------

![LOGO](g637065g09c01.jpg)

Multi-Lever Growth Strategy Supported by Strong Foundation Four-Pillar Growth Strategy Grow and deepen relationships Strengthen and build capabilities Create and deliver innovative solutions Expand into adjacent and non-healthcare markets Strong, stable cash flow supports investments in growth and return of capital to stockholders Innovation driven by strength of member network, diverse capabilities, robust data, acquisitions and talent Comprehensive technology and services platform Highly engaged culture Confidential© 2023. All rights reserved. Premier Inc. 7

------

![LOGO](g637065g10c01.jpg)

Advancing Multi-Year Growth Strategy Grow and deepen relationships • Continue to grow number of members and other customers and expand existing relationships • Collaborating and co-investing with healthcare providers and suppliers to improve domestic manufacturing and supply chain resiliency Strengthen and build capabilities • Acquisition of Invoice Delivery Services, L.P. key assets in March 2021; rebranded as Remitra™ • Contigo Health™ acquisition of TRPN\* key assets in October 2022 • Capturing more member spend in non-acute GPO; delivered double-digit revenue growth in FY22 vs. FY21 • Enhanced PINC AI™ Clinical Decision Support prior authorization solutions with utilization management capabilities Create and deliver innovative solutions • Launched analytics to predict supply chain shortages within 30-60 days with 95% accuracy • Launched Remitra™ Cash Flow Optimizer in FY 1Q23 to help health systems unlock working capital • Partnering with Qventus, an AI-powered software company that automates healthcare operations • Launched PINC AI's HCC-coding\*\* solutions to help ensure providers receive appropriate payment for care provided Expand into adjacent and non-healthcare markets Produced adjacent markets revenue growth of ~30% in FY2022 vs. FY2021 Grew Contigo Health revenue and participants in programs and services by ~30% in FY2022 vs. FY2021 Expect to grow through TRPN and launch Contigo Health ConfigureNet™ in CY2023 Continue to expand PINC AI™ Applied Sciences partnerships with pharmaceutical, medical device and diagnostics customers \* On October 13, 2022, Premier, Inc. subsidiary Contigo Health, LLC completed its acquisition of key assets of TRPN Direct Pay, Inc. and Devon Health, Inc. (collectively, "TRPN") \*\* HCC = Hierarchal condition category Confidential© 2023. All rights reserved. Premier Inc. 8

------

![LOGO](g637065g11c01.jpg)

Strong Financial Position with Balanced Approach to Capital Deployment Generate significant, stable cash flow Strong and flexible balance sheet Balanced capital deployment approach - Reinvestment in organic growth - Disciplined acquisitions and investments to support strategic goals - Return of capital to stockholders Confidential© 2023. All rights reserved. Premier Inc. 9

------

![LOGO](g637065g12c01.jpg)

Well-Positioned for Sustainable, Multi-Year Growth • Established industry leader operating in critical and growing markets • Long-standing strategic and collaborative member relationships • Leveraging comprehensive and scalable technology and services platform • Providing differentiated healthcare solutions • Executing focused, multi-year growth strategy • Driving innovation and performance through highly engaged culture • Maintaining strong financial position with balanced approach to capital deployment Making a Premier Impact Confidential© 2023. All rights reserved. Premier Inc. 10

## Exhibit 99.2

**Exhibit 99.2**![LOGO](g637065g40x04.jpg)

**Premier Inc. to Participate in 41<sup>st</sup> Annual J.P. Morgan** 

**Healthcare Conference on January 10, 2023** 

**CHARLOTTE, NC, Jan. 3, 2023 –** <u>Premier Inc.</u> (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. The company's formal presentation will begin at 11:15 a.m. PST (2:15 p.m. EST) and will include a question-and-answer session with the host analyst immediately following the conclusion of its presentation.

A link to the live audio webcast, as well as a replay of this event, will be available on the company's website at <u>Events and Presentations</u>.

**About Premier, Inc.** 

Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,400 U.S. hospitals and health systems and approximately 250,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier's news and investor sites on <u>www.premierinc.com</u>, as well as <u>Twitter</u>, <u>Facebook</u>, <u>LinkedIn</u>, <u>YouTube</u>, <u>Instagram</u> and <u>Premier's blog</u> for more information about the company.

**Contacts:** 

---

| | |
|:---|:---|
| **Investor contact:** | **Media contact:** |
| Angie McCabe | Amanda Forster |
| Vice President, Investor Relations | Vice President, Public Relations |
| 704.816.3888 | 202.879.8004 |
| angie_mccabe@premierinc.com | amanda_forster@premierinc.com |

---